ImmunityBio (IBRX) Cash from Investing Activities Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.52% |
| Dec 31, 2025 | 42.01% |
| Sep 30, 2025 | -26.21% |
| Jun 30, 2025 | -25.04% |
| Mar 31, 2025 | -21.66% |
| Dec 31, 2024 | 1.21% |
| Sep 30, 2024 | 30.21% |
| Jun 30, 2024 | -45.52% |
| Mar 31, 2024 | -12.85% |
| Dec 31, 2023 | -32.39% |
| Sep 30, 2023 | -23.96% |
| Jun 30, 2023 | -19.16% |
| Mar 31, 2023 | -37.45% |
| Dec 31, 2022 | -24.22% |
| Sep 30, 2022 | -16.74% |
| Jun 30, 2022 | 15.48% |
| Mar 31, 2022 | -44.60% |
| Dec 31, 2021 | -74.72% |
| Sep 30, 2021 | 9.07% |
| Jun 30, 2021 | 24.85% |
| Mar 31, 2021 | 18.25% |
| Dec 31, 2020 | 15.37% |
| Sep 30, 2020 | -144.28% |
| Jun 30, 2020 | 94.15% |
| Mar 31, 2020 | 57.00% |
| Dec 31, 2019 | 215.10% |
| Sep 30, 2019 | 148.32% |
| Jun 30, 2019 | 259.54% |
| Mar 31, 2019 | -527.53% |